Clinical Trials Directory

Trials / Completed

CompletedNCT01102647

Cholesterol Metabolism in Heterozygous Phytosterolemia

Assessment of Cholesterol Metabolism in Heterozygous Phytosterolemia

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
University of Manitoba · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to examine the effect of plant sterols on cholesterol absorption and synthesis in people with heterozygous phytosterolemia.

Detailed description

A plant sterol supplementation study will be conducted in individuals who are heterozygous for phytosterolemia compared to non-carriers. The study will use a double-blind, randomised, crossover, placebo-controlled design in which participants will consume 2 treatments including 1.6 g of plant sterol pills and a placebo pill, each for 4 weeks. A 4 week washout period will separate the two treatment periods. Plant sterol concentrations will be measured by gas liquid chromatography and absorption will be measured by the ratio of campesterol to lathosterol in plasma. Cholesterol absorption and synthesis will be measured by dual stable isotope technique, involving simultaneous administration of 13C-cholesterol and deuterium oxide, respectively.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTphytosterol ester1.6 g phytosterols/day for 29 days

Timeline

Start date
2010-04-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2010-04-13
Last updated
2011-05-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01102647. Inclusion in this directory is not an endorsement.